Overcoming the Moderate Efficacy Conundrum in PDE4 Inhibition through Hidradenitis Suppurativa
Time: 11:30 am
day: Day 2 AM - Track B
Details:
- Outlining PDE4i mode of action and the therapeutic potential to treat across numerous indications with serious unmet need
- Identifying subtypes to target B & D specificity in candidate compound
- Championing an oral delivery method with a good safety profile drug candidate
